Medicare Enrolled

Dr. Jaime Quesada, MD

Pulmonary Disease · El Paso, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
4305 N MESA ST, El Paso, TX 79902
9155322477
Registered in NPPES since 2005
NPI: 1578563862 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Quesada from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Quesada? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Quesada

Dr. Jaime Quesada is a pulmonary disease specialist in El Paso, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Quesada performed 1,147 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Quesada received a total of $7,589 from 31 pharmaceutical and/or device companies across 420 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Quesada is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 43% volume in TX $7,589 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,147
Medicare services
Top 43% in TX for pulmonary disease
Not available
Unique patients (not deduplicated)
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
481 $91 $304
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
102 $8 $80
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
85 $28 $91
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
85 $41 $134
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
83 $40 $128
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
69 $62 $215
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
62 $10 $34
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
55 $23 $80
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
32 $71 $266
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
28 $125 $395
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
27 $12 $40
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
16 $23 $81
Quadrivalent influenza vaccine, cell-culture derived
A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics.
11 $33 $70
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
11 $29 $45
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,589
Total received (2018-2024)
Avg $1,084/year across 7 years
Top 25% in TX for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
420
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,524
2023
$1,574
2022
$892
2021
$815
2020
$629
2019
$1,147
2018
$1,007

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$576
GENZYME CORPORATION
$259
Regeneron Healthcare Solutions, Inc.
$231
GlaxoSmithKline, LLC.
$146
Boehringer Ingelheim Pharmaceuticals, Inc.
$61
INOGEN, INC.
$56
Mylan Specialty L.P.
$51
Actelion Pharmaceuticals US, Inc.
$23
Amgen Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$20
Eurofins Viracor, LLC
$17
Baxter Healthcare
$16
Insmed, Inc.
$14
Philips North America LLC
$13
Top 3 companies account for 69.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,625
GlaxoSmithKline, LLC.
$1,499
Mylan Specialty L.P.
$670
Boehringer Ingelheim Pharmaceuticals, Inc.
$404
GENZYME CORPORATION
$317
Regeneron Healthcare Solutions, Inc.
$312
Novartis Pharmaceuticals Corporation
$243
Actelion Pharmaceuticals US, Inc.
$238
Grifols USA, LLC
$192
United Therapeutics Corporation
$125
Electromed, Inc.
$121
Insmed, Inc.
$115
Genentech USA, Inc.
$95
Amgen Inc.
$67
Philips Electronics North America Corporation
$65
Sunovion Pharmaceuticals Inc.
$59
INOGEN, INC.
$56
ABBVIE INC.
$53
Gilead Sciences, Inc.
$44
PFIZER INC.
$43
Teva Pharmaceuticals USA, Inc.
$38
Biogen, Inc.
$37
Inogen, Inc.
$31
Advanced Respiratory, Inc
$23
E.R. Squibb & Sons, L.L.C.
$22
Bayer Healthcare Pharmaceuticals Inc.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$20
Eurofins Viracor, LLC
$17
Baxter Healthcare
$16
Philips North America LLC
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 63.2% of all-time payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · AIRSUPRA · ANORO · ANORO ELLIPTA · AVAGE · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · CHANTIX · DUPIXENT · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · LONHALA MAGNAIR · Life 2000 Ventilation System · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPINRAZA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UPTRAVI · Veklury · Wellcentive Undiv · XOLAIR · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in El Paso?
Compare pulmonary diseases in the El Paso area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
13
County median income
$58,859
Nearest hospital to ZIP centroid (approximate)
THE HOSPITALS OF PROVIDENCE - MEMORIAL CAMPUS
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Quesada is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Quesada experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Quesada performed 481 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Quesada receive payments from pharmaceutical companies?
Yes. Dr. Quesada received a total of $7,589 from 31 companies across 420 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Quesada's costs compare to other pulmonary diseases in El Paso?
Dr. Quesada's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Quesada) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →